The addition of lenvatinib/pembrolizumab to TACE showed a numerical improvement in PFS, but longer follow-up is necessary to ...

Findings from an exploratory 2a study showed improvements in patients with cancer cachexia with PH284 compared with placebo.

An APP’s research is focused on chemo-induced peripheral neuropathy in Black breast cancer survivors and its impact on their long-term quality of life. Given the significant number of breast cancer ...